• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    3 Japanese Dividend Stocks For Steady Income Growth

    Simply Wall St·07/25/2026 01:34:42
    語音播報

    With inflation, energy prices and interest rate expectations all in focus, many investors are looking for income streams that feel steadier than the latest headline. That is where Dividend Powerhouses with yields above 5% and covered, growing payouts can help provide a clearer framework for building a portfolio around regular cash returns. This article explains how this screener filters for companies that combine higher yields with dividend stability. It then highlights 3 of the stocks from the Dividend Powerhouses screener that may merit further research if you want income to play a bigger role in your long term plan.

    Canon (TSE:7751)

    Overview: Canon is a diversified technology company that makes printers, cameras, medical imaging systems and industrial equipment, selling these products and related services worldwide under the Canon brand.

    Operations: Canon generates most of its ¥4.0t revenue from Printing (¥2.5t), followed by Imaging (¥1.1t), Medical (¥585.4b) and Industrial (¥360.6b), with additional contributions from other corporate activities.

    Market Cap: ¥3.8t

    Income investors looking at Canon get a mix of strong recent earnings momentum, a P/E that is well below many tech peers and an active share buyback program that has already retired about 4.5% of the share count, yet there are still some important trade offs to weigh. The company is using its broad printing, imaging and medical platforms to generate profits, but revenue and earnings growth are only moderate and future ROE is projected to sit near 10.4%. On top of that, the dividend record is uneven and governance flags, such as limited board independence, matter if you want reliable income. The key question is whether the current valuation and cash returns compensate you for those risks.

    Canon’s earnings momentum, lower P/E and buybacks could be masking a deeper story about how much room is left for income and valuation to work together, and the 4 key rewards and 1 important warning sign might reveal the twist investors are missing

    TSE:7751 P/E Ratio as at Jul 2026
    TSE:7751 P/E Ratio as at Jul 2026

    Daiichi Sankyo Company (TSE:4568)

    Overview: Daiichi Sankyo Company is a global pharmaceutical company focused on oncology and specialty medicines, supplying cancer treatments like Enhertu and Datroway alongside therapies for cardiovascular disease, metabolic disorders, migraines, osteoporosis and vaccines.

    Operations: Daiichi Sankyo Company generates about ¥2.1t in revenue from its Pharmaceutical Operation, with sales spread across Japan, the United States, Europe and other regions.

    Market Cap: ¥5.0t

    Daiichi Sankyo Company stands out in the Dividend Powerhouses screener because its 3.57% yield sits on top of a fast growing oncology franchise, with EU and U.S. approvals for antibody drug conjugates like Enhertu and Datroway supporting a strong revenue pipeline and milestone payments from partners such as AstraZeneca and Merck. At the same time, a rich drug pipeline, global biomarker collaborations and revenue forecasts that are expected to outpace the broader Japanese market give the stock a growth angle that many income options lack. The trade off is clear: earnings have recently declined 12.1%, profit margins are compressing, dividend coverage by free cash flow looks tight and funding is skewed to external borrowing. The key question is how these strengths and pressure points balance out for long term income focused investors.

    Daiichi Sankyo Company’s oncology engine and 3.57% yield appear to be decoupling from typical pharma income plays. However, the tension between growth, cash flow and debt is sharper than it seems, and the analyst forecasts for Daiichi Sankyo Company hints at where that trade off could really land.

    TSE:4568 Earnings & Revenue Growth as at Jul 2026
    TSE:4568 Earnings & Revenue Growth as at Jul 2026

    SoftBank (TSE:9434)

    Overview: SoftBank is a Japanese telecom and internet group that provides mobile and fixed-line phone services, broadband, cloud and data center capabilities, digital advertising, e-commerce and cashless payment services to consumers and businesses across Japan.

    Operations: SoftBank generates about ¥7.0t in revenue, led by Consumer services at roughly ¥3.0t, followed by Media & EC at about ¥1.7t, Distribution at about ¥1.1t, Enterprise at about ¥1.0t, Financial services at about ¥0.4t, with smaller contributions from Other activities and unallocated adjustments.

    Market Cap: ¥10.6t

    SoftBank offers a higher yielding income story tied to everyday services that Japanese consumers and companies already rely on, from mobile contracts to broadband to QR code payments. Recent partnerships such as the NVIDIA Cosmos collaboration on physical AI and talks with Seven & i around PayPay point to new ways to use its telecom base. On the other hand, the stock carries high leverage, governance turnover and a P/E above peers, which all raise the bar for execution. The key question is whether that combination of cash returns and growth projects compensates for the additional balance sheet and governance risk.

    SoftBank’s higher yield, heavy leverage and new AI partnerships suggest investors may be missing how this income story really hangs together. The 3 key rewards and 1 important warning sign could clarify the one tension that changes the whole picture.

    TSE:9434 P/E Ratio as at Jul 2026
    TSE:9434 P/E Ratio as at Jul 2026

    The three stocks covered here are only a starting point, and the full Dividend Powerhouses (3%+ Yield) screener surfaces 468 more companies with dividend profiles and stories that may be just as compelling for income focused investors. Use Simply Wall St to identify, analyze and filter for the exact catalysts, payout trends and risk reward narratives that matter to you so you can focus on the highest conviction income ideas for your watchlist.

    Take Control of Your Investment Journey

    If Daiichi Sankyo Company or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

    Seeking Alternatives Before The Crowd Moves?

    Fresh ideas do not wait. While others react to yesterday's headlines, you can scan for tomorrow's potential breakouts and steady cash generators under the radar for now, act now.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.